UBS lowered the firm’s price target on Expedia to $144 from $151 and keeps a Neutral rating on the shares. Expedia remains a self-help execution story beyond the mixed Q4 results and below-expectations guidance for Q1, the analyst tells investors in a research note. Major product updates rolling out in 2024 could change its Gross Bookings, revenue, and profit growth trajectories, but the likelihood for success or failure of these initiatives depends on management, the firm adds.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on EXPE: